Guia Clínica de l'HIV 2003 - Sida Studi

lanch.QXD 4/03/03 06:02 Página 414– Ayuso-Mateos, J.L. Trastornos neuropsiquiátricos en el SIDA. McGraw-Hill Interamericana,Madrid 1997.– Bachanas, P.J., Kullgren, K.A., Morris, M.K., Jones, J.S. Influence of family factorsand illness parameters on HIV-infected children’s cognnitive, academic andpsychological functioning. NIMH Conference on the role of families in adapting toan Preventing HIV/AIDS. Washington, DC, July 1998.– Blanch, J., Corbella, B., García, F., Parellada, E., Gatell, J.M. Maniac syndrome associatedwith efavirenz overdose. Clinical Infectious Diseases 2001; 33: 270-271.– Blanch, J., Martínez, E., Rousand, A. Preliminary data of a prospective study onthe neuropsychiatric side-effects after inhibition of efavirenz. J Acquir ImmuneSyndr 2001; 27: 336-343.– Borg, L., Kreek, M. Clinical problems associated with interactions between methadonepharmacotherapy and medications used in the treatment of HIV-1 positiveand AIDS patients. Current opinion in Psychiatry 1995; 8: 199-202.– Breibart, W., Marotta, R., Platt, M. i cols. A double-blind trial of haloperidol, chlorpromazine,and lorazepam in the treatment of delirium in hospitalized AIDSpatients. Am J Psychiatry 1996; 153: 231-237.– Catalan, J., Burgess, A., Klimes, I. Psychological medicine of HIV infection.Oxford University Press, New York 1995.– Childs, E.A., Lyles, R.H., Selnes, O.A. i cols. Plasma viral load and CD4 lymphocytespredict HIV-associated dementia and sensory neuropathy. Neurology1999; 52: 607-613.– Confrancesco, J., Whalen, J.J., Dobs, A.S. Testosterone replacement options forHIV-infeced men. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 254-265.– Cornblath, D.R., McArthur, J.C. Predominantly sensory neuropathy in patientswith AIDS and AIDS-related complex. Neurology 1988; 38: 794-796.– Cote, T., Biggar, R., Dannenberg, A. Risk of suicide among persons with AIDS:A national assessment. JAMA 1992; 268: 2066-2068.– Ellen, S.R., Judd, F.K., Mijch, A.M., Cochram, A. Secondary mania in patientswith HIV infection. Aust NZ J Psychiatry 1999; 33: 353-360.– Elliot, A.J., Russo, J., Bergam, K., Claypoole, K., Uldall, K.K., Roy-Byrne, P.P.Antidepressant efficacy in HIV-seropositive outpatients with major depressivedisorder: An open trial of nefazodone.– Ellis, R.J., Deutsch, R., Heaton, R.K., Marcotte, T.D., McCutchan, J.A., Abramson,I., Thal, L.J., Atkinson, J.H., Wallace, M.R., Grant, I. (San Diego HIV NeurobehavioralResearch Center Group): Neurocognitive impairment is an independentrisk factor dor death in HIV infection. Arch Neurol 1997; 416-424.414